Copyright: ©Author(s) 2026.
World J Psychiatry. Nov 19, 2026; 16(11): 122026
Published online Nov 19, 2026. doi: 10.5498/wjp.122026
Published online Nov 19, 2026. doi: 10.5498/wjp.122026
Table 2 Changes in serum proprotein convertase subtilisin/kexin type 9 concentrations over 12 weeks
| Time point | Treatment group (ng/mL) | Control group (ng/mL) | P value |
| Baseline | 385.6 ± 78.4 | 378.2 ± 76.9 | 0.587 |
| 4 weeks | 245.7 ± 58.3 | 365.8 ± 72.1 | < 0.001 |
| 8 weeks | 192.5 ± 48.6 | 321.4 ± 69.5 | < 0.001 |
| 12 weeks | 156.3 ± 42.1 | 298.5 ± 68.7 | < 0.001 |
- Citation: Song HY, Yang Y, Sun XY, Zhang MJ, Wang SG. Serum proprotein convertase subtilisin/kexin type 9 levels correlate with depression severity in post-stroke patients. World J Psychiatry 2026; 16(11): 122026
- URL: https://www.wjgnet.com/2220-3206/full/v16/i11/122026.htm
- DOI: https://dx.doi.org/10.5498/wjp.122026